$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
美国FDA批准艾伏尼布ivosidenib用于治疗急性髓系白血病
2025-10-19 11:44:20
Check Details
急性T-淋巴细胞白血病患者全新选择——奈拉滨(Nelarabine)
2025-10-19 11:44:20
Check Details
淋巴细胞性白血病药-奈拉滨(Atriance)
2025-10-19 11:44:20
Check Details
奈拉滨治疗急性T淋巴细胞白血病取得较好的疗效
2025-10-19 11:44:20
Check Details
白血病新药吉瑞替尼在中国获批!可显著提高生存率
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病怎么服用?需要注意什么事项?
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病疗效如何?达沙替尼副作用是什么?
2025-10-19 11:44:20
Check Details
T细胞恶性肿瘤克星——奈拉滨Atriance(诺华德国版)
2025-10-19 11:44:20
Check Details
400万白血病患者群体,我们发现了好药奈拉宾!
2025-10-19 11:44:20
Check Details
格拉斯吉布薄膜片效果怎么样?格拉斯吉布薄膜片用法用量是怎样的?
2025-10-19 11:44:20
Check Details
恩西地平Enasidenib是针对治疗急性髓性白血病新药
2025-10-19 11:44:20
Check Details
阿卡替尼(Acalabrutinib)会耐药吗?要注意什么
2025-10-19 11:44:20
Check Details
1
2
...
648
649
650
651
652
653
654
...
938
939
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
2
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
3
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
4
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
5
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
6
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
7
Anagrelide and Myelofibrosis Risk: Controversy and Monitoring in ET Treatment
8
Acalabrutinib Dosing Guide: Dosage, Duration and Precautions
9
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
10
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
11
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
12
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights